Programmed Cell Death 4 (PDCD4) Enhances the Sensitivity of Gastric Cancer Cells to TRAIL-Induced Apoptosis by Inhibiting the PI3K/Akt Signaling Pathway

被引：0

作者：

Wang, Wei-Qiang ^{[1
]}

Zhang, Hao ^{[1
]}

Wang, Hong-Bin ^{[1
]}

Sun, Yong-Gang ^{[1
]}

Peng, Zhi-Hong ^{[1
]}

Zhou, Gang ^{[1
]}

Yang, Shi-Ming ^{[1
]}

Wang, Rong-Quan ^{[1
]}

Fang, Dian-Chun ^{[1
]}

机构：

[1] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China

来源：

MOLECULAR DIAGNOSIS & THERAPY | 2010年 / 14卷 / 03期

关键词：

TRANSLATIONAL REGULATION; AKT PHOSPHORYLATION; KINASE-B; EXPRESSION; SUPPRESSOR; GROWTH; PROGRAMMED-CELL-DEATH-4; TUMORIGENESIS; DEGRADATION; ACTIVATION;

D O I：

10.1007/BF03256368

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Objective: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is thought to be a promising anti-neoplastic agent because of its ability to selectively induce apoptosis in cancer cells. However, some cancer cells are resistant to TRAIL. The mechanisms underlying this resistance are unclear. The aim of this study was to explore the role of programmed cell death 4 (PDCD4) in regulating TRAIL sensitivity in gastric cancer cells. Methods: PDCD4 complementary DNA and PDCD4-specific short-hairpin RNA (shRNA) fragments were transfected into TRAIL-sensitive and -resistant gastric cancer cells. Expression of PDCD4 and Akt was detected via western blot. Cell survival and apoptosis were measured using 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry (FCM) assays. Results: We found that upregulation of PDCD4 enhanced TRAIL sensitivity in gastric cancer cells. Downregulation of PDCD4 decreased TRAIL sensitivity. Inhibition of Akt by the phosphoinositide 3-kinase (PI3K) inhibitor LY294002 induced PDCD4 activity and enhanced TRAIL sensitivity in TRAIL-resistant gastric cancer cells. Conclusion: We demonstrated that PDCD4 regulates TRAIL sensitivity in gastric cancer cells by inhibiting the PI3K/Akt signaling pathway.

引用

页码：155 / 161

页数：7

共 49 条

[1] Upregulated Akt signaling adjacent to gastric cancers: implications for screening and chemoprevention [J].

Ang, KL ;

Shi, DL ;

Keong, WW ;

Epstein, RJ .

CANCER LETTERS, 2005, 225 (01) :53-59

[2] Safety and antitumor activity of recombinant soluble Apo2 ligand [J].

Ashkenazi, A ;

Pai, RC ;

Fong, S ;

Leung, S ;

Lawrence, DA ;

Masters, SA ;

Blackie, C ;

Chang, L ;

McMurtrey, AE ;

Hebert, A ;

DeForge, L ;

Koumenis, IL ;

Lewis, D ;

Harris, L ;

Bussiere, J ;

Koeppen, H ;

Shahrokh, Z ;

Schwall, RH .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162

[3] Akt activation by growth factors is a multiple-step process: the role of the PH domain [J].

Bellacosa, A ;

Chan, TO ;

Ahmed, NN ;

Datta, K ;

Malstrom, S ;

Stokoe, D ;

McCormick, F ;

Feng, JN ;

Tsichlis, P .

ONCOGENE, 1998, 17 (03) :313-325

[4] The phosphoinositide 3-kinase pathway [J].

Cantley, LC .

SCIENCE, 2002, 296 (5573) :1655-1657

[5] Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma [J].

Capodanno, Alessandra ;

Camerini, Andrea ;

Orlandini, Cinzia ;

Baldini, Editta ;

Resta, Maria Letizia ;

Bevilacqua, Generoso ;

Collecchi, Paola .

HUMAN PATHOLOGY, 2009, 40 (10) :1408-1417

[6] Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway [J].

Carayol, Nathalie ;

Katsoulidis, Efstratios ;

Sassano, Antonella ;

Altman, Jessica K. ;

Druker, Brian J. ;

Platanias, Leonidas C. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (13) :8601-8610

[7] AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation [J].

Chan, TO ;

Rittenhouse, SE ;

Tsichlis, PN .

ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :965-1014

[8] Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer [J].

Chen, XF ;

Thakkar, H ;

Tyan, F ;

Gim, S ;

Robinson, H ;

Lee, C ;

Pandey, SK ;

Nwokorie, C ;

Onwudiwe, N ;

Srivastava, RK .

ONCOGENE, 2001, 20 (42) :6073-6083

[9] Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis [J].

Chen, Y ;

Knösel, T ;

Kristiansen, G ;

Pietas, A ;

Garber, ME ;

Matsuhashi, S ;

Ozaki, I ;

Petersen, I .

JOURNAL OF PATHOLOGY, 2003, 200 (05) :640-646

[10] Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy [J].

Chinnaiyan, AM ;

Prasad, U ;

Shankar, S ;

Hamstra, DA ;

Shanaiah, M ;

Chenevert, TL ;

Ross, BD ;

Rehemtulla, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1754-1759

← 1 2 3 4 5 →